Skip to main content
. 2021 Apr 14;11:8109. doi: 10.1038/s41598-021-87645-6

Table 5.

Number of patients harboring somatic gene alterations according to the site of the sample used for clinical sequencing.

Primary tumor (n = 13) Metastatic tumor (n = 11) P value
TP53 4 (31%) 3 (27%) 0.85
PIK3CA 5 (38%) 2 (18%) 0.28
AKT1 2 (15%) 4 (36%) 0.24
ESR1 3 (23%) 3 (27%) 0.81
MYC 2 (15%) 1 (9%) 0.64